Blood Cancer Awareness Month

CANCER BUZZ · Sep 23, 2025 · 7m

According to Blood Cancer United (formerly the Leukemia & Lymphoma Society), approximately every 3 minutes, 1 person in the United States is diagnosed with leukemia, lymphoma, or myeloma. AML is a heterogeneous hematologic malignancy; despite advances in treatment, AML remains challenging to cure. Integrating new treatment options for patients with refractory acute myeloid leukemia (AML), including menin inhibitors, into routine oncology care can help bring novel therapies to patients with relapsed or refractory AML. ACCC is committed to providing information on the latest research and…